SFA Therapeutics names CMO to strengthen management team

3 May 2024
biotech-appt

Pennsylvania, USA-based clinical-stage biotech SFA Therapeutics has appointed of Dr Stefan Weiss as chief medical officer in a move to strengthen its management team.

Dr Weiss is a physician-scientist and entrepreneur with 25 years of experience in the healthcare and life sciences industries. Most recently, Dr Weiss was the managing director of dermatology at OM1, a company focused on health care data analytics and artificial intelligence.

In this position, he was responsible for deepening OM1's clinical focus and expertise around Immunology. He provided guidance on the scientific standards and clinical relevance of real-world data offerings across immunologic diseases. In addition, he oversaw the development of prospective studies to collect real-world evidence, including the ClinPro Derm Protocol.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

More on this story...



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Biotechnology